16.28
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Dentsply Sirona Inc stock is traded at $16.28, with a volume of 1.43M.
It is down -1.48% in the last 24 hours and down -15.74% over the past month.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
See More
Previous Close:
$16.55
Open:
$16.63
24h Volume:
1.43M
Relative Volume:
0.57
Market Cap:
$3.28B
Revenue:
$3.90B
Net Income/Loss:
$-413.00M
P/E Ratio:
-7.8647
EPS:
-2.07
Net Cash Flow:
$365.00M
1W Performance:
-14.41%
1M Performance:
-15.74%
6M Performance:
-34.78%
1Y Performance:
-50.99%
Dentsply Sirona Inc Stock (XRAY) Company Profile
Name
Dentsply Sirona Inc
Sector
Industry
Phone
844-546-3722
Address
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XRAY
Dentsply Sirona Inc
|
16.29 | 3.28B | 3.90B | -413.00M | 365.00M | -2.07 |
![]()
ISRG
Intuitive Surgical Inc
|
577.73 | 205.74B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
229.10 | 65.11B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
94.64 | 46.26B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
234.76 | 34.51B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
92.52 | 18.19B | 3.90B | 392.30M | 288.10M | 1.95 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
Jan-23-25 | Downgrade | Jefferies | Buy → Hold |
Jan-07-25 | Downgrade | Evercore ISI | Outperform → In-line |
Dec-04-24 | Initiated | Mizuho | Neutral |
Nov-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Oct-25-24 | Reiterated | Needham | Buy |
Aug-20-24 | Reiterated | Needham | Buy |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Nov-16-23 | Initiated | Needham | Buy |
Nov-10-23 | Upgrade | William Blair | Mkt Perform → Outperform |
Jan-12-23 | Upgrade | William Blair | Underperform → Mkt Perform |
Aug-05-22 | Downgrade | William Blair | Mkt Perform → Underperform |
Jun-02-22 | Upgrade | UBS | Neutral → Buy |
Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Apr-20-22 | Downgrade | William Blair | Outperform → Mkt Perform |
Apr-19-22 | Downgrade | BofA Securities | Buy → Neutral |
Apr-19-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-31-22 | Initiated | Morgan Stanley | Overweight |
Oct-01-21 | Resumed | Credit Suisse | Outperform |
Aug-09-21 | Reiterated | H.C. Wainwright | Neutral |
Aug-06-21 | Reiterated | Barrington Research | Outperform |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Mar-02-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Mar-02-21 | Reiterated | H.C. Wainwright | Neutral |
Jan-05-21 | Reiterated | H.C. Wainwright | Neutral |
Dec-18-20 | Downgrade | Stifel | Buy → Hold |
Nov-17-20 | Downgrade | Barclays | Equal Weight → Underweight |
Nov-09-20 | Reiterated | H.C. Wainwright | Neutral |
Oct-22-20 | Upgrade | Guggenheim | Neutral → Buy |
Aug-10-20 | Reiterated | H.C. Wainwright | Neutral |
Jun-16-20 | Initiated | Piper Sandler | Overweight |
Jun-15-20 | Reiterated | H.C. Wainwright | Neutral |
May-27-20 | Upgrade | Evercore ISI | In-line → Outperform |
May-11-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Apr-24-20 | Reiterated | H.C. Wainwright | Neutral |
Apr-08-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Apr-07-20 | Downgrade | Goldman | Buy → Neutral |
Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Mar-03-20 | Reiterated | H.C. Wainwright | Neutral |
Feb-19-20 | Reiterated | Stifel | Buy |
Dec-11-19 | Downgrade | JP Morgan | Overweight → Neutral |
Aug-02-19 | Upgrade | Wellington Shields | Hold → Gradually Accumulate |
Jul-26-19 | Initiated | Evercore ISI | In-line |
Jul-09-19 | Reiterated | H.C. Wainwright | Neutral |
May-30-19 | Initiated | Wolfe Research | Peer Perform |
View All
Dentsply Sirona Inc Stock (XRAY) Latest News
Investing in Dentsply (XRAY)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance
Dental Burs Market Is Booming So Rapidly | Komet, Brasseler, Dentsply Sirona - openPR
Correction: DENTSPLY SIRONA's Q4 Adjusted Earnings, Revenue Decline; 2025 Guidance Initiated; Dividend Maintained - Marketscreener.com
Dental Laboratories Market Growth in Future Scope 2025-2032 | - openPR
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation - Markets Insider
DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16 - Yahoo Finance
Needham & Company LLC Issues Pessimistic Forecast for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price - MarketBeat
Class Action Filed Against Dentsply Sirona Inc. (XRAY)January 27, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
DENTSPLY SIRONA (NASDAQ:XRAY) Issues Earnings Results, Misses Expectations By $0.21 EPS - MarketBeat
UBS maintains Buy on DENTSPLY SIRONA stock, price target at $27 - Investing.com
Relative Strength Alert For DENTSPLY SIRONA - Nasdaq
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Down 7.7% on Disappointing Earnings - MarketBeat
Barrington Adjusts Price Target on DENTSPLY SIRONA to $20 From $24, Keeps Outperform Rating - Marketscreener.com
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Declares $0.16 Quarterly Dividend - MarketBeat
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q4 2024 Earnings Call Transcript - Insider Monkey
Expert Outlook: Dentsply Sirona Through The Eyes Of 9 Analysts - Benzinga
DENTSPLY SIRONA, Inc. to Host Earnings Call - ACCESS Newswire
Dentsply Sirona Inc (XRAY) Q4 2024 Earnings Call Highlights: Nav - GuruFocus.com
Dentsply Sirona is leading dental innovation across the Asia - Dental Tribune International
Dentsply Sirona Inc (XRAY) Q4 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada
Dentsply Sirona Faces Challenges with 2024 Earnings - TipRanks
Macro Challenges, Byte Suspension, and Soft Demand Throw a Wrench In Dentsply Sirona's Recovery - Morningstar
Dentsply Sirona Q4: Earnings Miss, 10% Sales Drop, Soft 2025 Outlook And More - AOL
Needham cuts DENTSPLY stock target to $23, keeps buy rating By Investing.com - Investing.com South Africa
Earnings call transcript: Dentsply Sirona Q4 2024 shows sales decline, stock drops - Investing.com
Dentsply Sirona Reports Q4 2024 Revenue Decline Amidst Sector ChallengesNews and Statistics - IndexBox, Inc.
Dentsply Sirona Q4 24 Earnings Conference Call At 8:30 AM ET - Nasdaq
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results - TradingView
DENTSPLY SIRONA (NASDAQ:XRAY) Updates FY 2025 Earnings Guidance - MarketBeat
DENTSPLY SIRONA's Q4 Adjusted Earnings, Revenue Decline; 2025 Guidance Initiated; Dividend Maintained - Marketscreener.com
Dentsply International (XRAY) Misses Q4 Earnings and Revenue Estimates - Nasdaq
Dentsply Sirona shares fall over 2% on revenue miss, weak guidance - Investing.com Canada
DENTSPLY SIRONA Earnings Results: $XRAY Reports Quarterly Earnings - Nasdaq
Dentsply Sirona Issues FY25 Outlook - Nasdaq
Dentsply Sirona (NASDAQ:XRAY) Misses Q4 Sales Targets, Stock Drops - Yahoo Finance
Earnings Flash (XRAY) DENTSPLY Sirona Posts Q4 Adjusted EPS $0.26, vs. FactSet Est of $0.43 - Marketscreener.com
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook - GlobeNewswire
Dentsply Sirona Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights – XRAY - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - Markets Insider
Dentsply Sirona Q4 2024 Earnings Preview - MSN
Dental Crown Fixing Clip Market Booming Growth: Future Trends, - openPR
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q4 Results Tomorrow - Yahoo Finance
Endodontic Electric Motor System Market Detailed In New - openPR
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? - MSN
Dentsply (XRAY) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
XRAY LAWSUIT ALERT: Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Dental Veneers Market Expanding Rapidly | Key Trends & Forecast 2025-2032: Dentsply Sirona, Kuraray America - openPR
Tooth Etching Gel Market Generated Opportunities, Future Scope - openPR
XRAY Stockholders Have Opportunity to Lead Dentsply Sirona Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Composite Dental Restorative Material Market to Reach $887.02 Million, by 2032 at 7.2% CAGR: Allied Market Research - GlobeNewswire Inc.
Levi & Korsinsky Reminds Dentsply Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025XRAY - ACCESS Newswire
Dentsply Sirona Inc Stock (XRAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dentsply Sirona Inc Stock (XRAY) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
LUCIER GREGORY T | Director |
Nov 18 '24 |
Buy |
18.37 |
5,000 |
91,850 |
71,730 |
LUCIER GREGORY T | Director |
Nov 15 '24 |
Buy |
18.28 |
1,000 |
18,279 |
16,000 |
Campion Simon D | President, CEO & Member of BOD |
Nov 12 '24 |
Buy |
17.72 |
11,306 |
200,341 |
272,247 |
LUCIER GREGORY T | Director |
Aug 08 '24 |
Buy |
24.35 |
8,212 |
199,983 |
66,661 |
LUCIER GREGORY T | Director |
May 31 '24 |
Buy |
27.95 |
3,577 |
99,976 |
58,374 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):